BCL2L12 and glioblastoma: Another study (NCT03020017) investigates the efficacy of NU-0129, a spherical nucleic acid AuNP targeting BCL2L12, a protein family member, to cross the blood-brain barrier in patients with recurrent glioblastoma multiforme or gliosarcoma, showing promising results for potential glioblastoma treatment 192.